Related Experiment Video
Updated: Dec 27, 2025

Primordial Germ Cell Transplantation for CRISPR/Cas9-based Leapfrogging in Xenopus
Published on: February 1, 2018
Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders
Marianna Paulis1,2, Lucia Susani1,2, Alessandra Castelli1,2
1National Research Council (CNR)-IRGB/UOS, Milan, Italy.
Abstract:
Many human genetic diseases are associated with gross mutations such as aneuploidies, deletions, duplications, or inversions. For these "structural" disorders, conventional gene therapy, based on viral vectors and/or on programmable nuclease-mediated homologous recombination, is still unsatisfactory. To correct such disorders, chromosome transplantation (CT), defined as the perfect substitution of an endogenous defective chromosome with an exogenous normal one, could be applied. CT re-establishes a normal diploid cell, leaving no marker of the procedure, as we have recently shown in mouse pluripotent stem cells. To prove the feasibility of the CT approach in human cells, we used human induced pluripotent stem cells (hiPSCs) reprogrammed from Lesch-Nyhan (LN) disease patients, taking advantage of their mutation in the X-linked HPRT gene, making the LN cells selectable and distinguishable from the resistant corrected normal cells. In this study, we demonstrate, for the first time, that CT is feasible in hiPSCs: the normal exogenous X chromosome was first transferred using an improved chromosome transfer system, and the extra sex chromosome was spontaneously lost. These CT cells were functionally corrected and maintained their pluripotency and differentiation capability. By inactivation of the autologous HPRT gene, CT paves the way to the correction of hiPSCs from several X-linked disorders.
Insights
Chromosome transplantation successfully corrected genetic defects in human stem cells. This groundbreaking technique offers a new therapeutic avenue for treating genetic disorders by replacing faulty chromosomes with healthy ones.
Area of Science:
- Genetics
- Molecular Biology
- Stem Cell Research
Background:
- Structural genetic disorders often involve large chromosomal abnormalities.
- Current gene therapies are insufficient for correcting these complex mutations.
- Chromosome transplantation (CT) offers a novel approach for complete chromosomal replacement.
Purpose of the Study:
- To demonstrate the feasibility of chromosome transplantation (CT) in human cells.
- To correct genetic defects in human induced pluripotent stem cells (hiPSCs) from Lesch-Nyhan disease patients.
- To establish CT as a viable method for treating X-linked genetic disorders.
Main Methods:
- Utilized hiPSCs derived from Lesch-Nyhan disease patients with a selectable HPRT gene mutation.
- Employed an improved chromosome transfer system to introduce a normal exogenous X chromosome.
- Monitored spontaneous loss of the extra sex chromosome in recipient cells.
Main Results:
- Successfully achieved chromosome transplantation in hiPSCs, marking the first instance in human cells.
- CT cells exhibited functional correction of the HPRT gene defect.
- Transplanted cells retained pluripotency and differentiation capabilities.
- Demonstrated selective advantage of corrected cells due to HPRT gene inactivation.
Conclusions:
- Chromosome transplantation is a feasible and effective strategy for correcting genetic defects in hiPSCs.
- CT can restore normal diploid status and cellular function without leaving procedural markers.
- This approach holds significant promise for treating a range of X-linked disorders by correcting the underlying chromosomal defect.
Related Concept Videos
X-linked Traits
Sex-linked Disorders
X and Y Chromosomes
The germline cells such as egg and sperm cells carry only half the number of chromosomes, i.e., 22 autosomes and one sex chromosome. All eggs have an X chromosome, while sperm cells can carry an X or...
Karyotyping
Chromosomal Theory of Inheritance
X-Inactivation

